Connect with us

Technology

Cast & Crew Signs Definitive Agreement to Acquire Backstage Holdings

Avatar

Published

on

BURBANK, Calif., Feb. 1, 2022 /PRNewswire/ — Cast & Crew, a leading end-to-end cloud-based platform powering global entertainment production and content creation, today announced it has signed a definitive agreement to acquire Backstage Holdings (“Backstage”), a leading provider of talent marketplace and content creation tools for the creative economy. This transaction brings together two companies with the shared mission of making content creation more efficient and effective at scale. 

“This is a transformative acquisition for our company,” said John Berkley, Chief Executive Officer of Cast & Crew. “Cast & Crew has always been driven to solve the industry’s most challenging and complex problems. We believe that finding the best talent and creative resources is one of the most critical challenges in content creation today, and Backstage has proven themselves capable of making this difficult work so much easier for millions of industry participants. The addition of Backstage enhances the overall scope of our offerings and our ability to service the needs of studios, management companies, productions, and of course the talent and workforce that makes the magic happen. Together, we see a tremendous opportunity to deliver a true end-to-end platform for the array of companies and people working tirelessly to bring their creativity to life.” 

Backstage is the industry’s leading subscription-based marketplace for freelancers and creators in the entertainment and creative industries. Backstage’s web and mobile-based offerings help content creators and producers find creative talent, while helping millions of aspiring creatives find work, build their networks, and advance their careers. Backstage also owns complementary properties such as Voice123, a specialized subscription-based marketplace for voice actors, Film Freeway, a tech-enabled submission platform for the …

Full story available on Benzinga.com

Original Post: benzinga.com

Technology

Truist Sees 350% Upside on This Cancer-Focused Biopharma Stock – Read Why

Avatar

Published

on

Truist has initiated coverage on Verastem Oncology Inc (NASDAQ: VSTM) with a Buy rating and $6.00 price target, equivalent to approximately 350% upside.
Analyst Srikripa Devarakonda notes that trading at about 2-times cash, the stock is “undervalued” given its programs in two cancers.
Devarakonda adds that the Verastem base case is supported by a $470 million unadjusted U.S. opportunity in the ovarian cancer program, “early but strong” clinical data, and positive expert feedback.
Related: 

Full story available on Benzinga.com

Article: benzinga.com

Continue Reading

Technology

“Peek Performance”: Apple’s Next Hardware Event Happens on March 8

Avatar

Published

on

Enlarge (credit: Apple)

Apple will stream its next hardware event to the masses on March 8 at 10 am Pacific (1 pm Eastern), the company announced today. Invitations have already been sent to the press—though the event will be yet another prerecorded, streaming-only presentation with no media in attendance. Apple marketing SVP Greg Joswiak tweeted the now-customary Apple-logo-centric teaser video that doesn’t actually tease anything.

We never know exactly what will be announced at any given Apple event, but Bloomberg’s Mark Gurman reports that the lineup will include a refresh of the budget-friendly iPhone SE and the first iPad Air update in a little over a year.

Rumors have also circulated about updated designs and new Apple Silicon chips for the MacBook Air and the 13-inch MacBook Pro, and the high-end Intel Mac Mini, the 27-inch iMac, and the Mac Pro are all still running Intel chips. The characteristically cryptic “peek performance” tagline does at least hint at new chips for one or more Macs, whether that’s a truly next-gen Apple M2 for thin-and-light laptops or an M1 Pro/Max-focused refresh for the more powerful desktops.

Read 1 remaining paragraphs | Comments

Original Article: arstechnica.com

Continue Reading

Technology

Charles River’s Q4 Earnings Beats Street Expectation, Reaffirms FY22 Outlook

Avatar

Published

on

Charles River Laboratories International Inc’s (NYSE: CRLQ4 sales increased 14.4% Y/Y to $905.1 million, beating the consensus of $888.27 million.

Acquisitions contributed 5.9% to consolidated fourth-quarter revenue growth. Organic revenue growth was 10.5%, driven by contributions from all three business segments. 
Adjusted EPS reached $2.49 higher than $2.39 posted a year ago and …

Full story available on Benzinga.com

Article: benzinga.com

Continue Reading

Trending

WOC.io